Trial intelligence / Profile preview

Special Drug Use-Results Survey of Coralan in Chronic Heart Failure

jRCT1080225341Completed

Sponsor
Ono Pharmaceutical
Start
Aug 2020
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of ivabradine in chronic heart failure (CHF), sponsored by Ono Pharmaceutical. Started Aug 2020; status: completed.

02

Drugs

ivabradine
03

Conditions

chronic heart failure (CHF)

Beyond the preview

Go deeper on jRCT1080225341.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1080225341.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call